(Q39452131)

12 September 2017

title

Cystatin C: a predictor of hepatorenal syndrome in patients with liver cirrhosis (English)

1 reference

12 September 2017

0 references

1 reference

Mohammed A Sharawey

1

1 reference

12 September 2017

Eglal M Shawky

2

1 reference

12 September 2017

Lamia H Ali

3

1 reference

12 September 2017

Ahmed Ali Mohammed

4

1 reference

12 September 2017

Hatem A Hassan

5

1 reference

12 September 2017

Yasser M Fouad

6

1 reference

12 September 2017

language of work or name

1 reference

12 March 2011

1 reference

12 September 2017

published in

Hepatology international

1 reference

Acute kidney injury in cirrhosis

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12072-011-9266-Y

Ascites and hepatorenal syndrome in cirrhosis: pathophysiological basis of therapy and current management.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-011-9266-Y

Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-011-9266-Y

Female liver transplant recipients with the same GFR as male recipients have lower MELD scores--a systematic bias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-011-9266-Y

Pathogenesis and treatment of hepatorenal syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-011-9266-Y

The evaluation of renal function and disease in patients with cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-011-9266-Y

Plasma cystatin C as a marker of renal function in patients with liver cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-011-9266-Y

Determination of the production rate and non-renal clearance of cystatin C and estimation of the glomerular filtration rate from the serum concentration of cystatin C in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-011-9266-Y

Diagnostic value of serum cystatin C for evaluation of hepatorenal syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-011-9266-Y

Evaluation of serum cystatin C concentration as a marker of renal function in patients with cirrhosis of the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-011-9266-Y

Model for end-stage liver disease (MELD) and allocation of donor livers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-011-9266-Y

Predicting glomerular function from adjusted serum creatinine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-011-9266-Y

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-011-9266-Y

Transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis of individual patient data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-011-9266-Y

Cystatin C: a marker of glomerular filtration rate in liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-011-9266-Y

Re-weighting the model for end-stage liver disease score components

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-011-9266-Y

Assessment of prognosis of cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-011-9266-Y

The association between the serum sodium level and the severity of complications in liver cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-011-9266-Y

Hyponatremia in cirrhosis: Results of a patient population survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-011-9266-Y

A prognostic model for predicting survival in cirrhosis with ascites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-011-9266-Y

MELD score and serum sodium in the prediction of survival of patients with cirrhosis awaiting liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-011-9266-Y

Serum creatinine and bilirubin predict renal failure and mortality in patients with spontaneous bacterial peritonitis: a retrospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-011-9266-Y

Selecting an optimal prognostic system for liver cirrhosis: the model for end-stage liver disease and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-011-9266-Y

Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-011-9266-Y

Unpredictability of clinical evaluation of renal function in cirrhosis. Prospective study

21 January 2018

1 reference

12 December 2020

Performance of the new MELD-Na score in predicting 3-month and 1-year mortality in Chinese patients with chronic hepatitis B

1 reference

12 December 2020

Alteration and significance of serum cardiac troponin I and cystatin C in preeclampsia

1 reference

12 December 2020

Glucocorticoids and increased serum cystatin C concentrations

1 reference

12 December 2020

Serum cystatin C measured by automated immunoassay: a more sensitive marker of changes in GFR than serum creatinine

1 reference

12 December 2020

Correlation of serum concentrations of cystatin C and creatinine to inulin clearance in liver cirrhosis

1 reference

12 December 2020

Diagnostic value of plasma cystatin C as a glomerular filtration marker in decompensated liver cirrhosis

1 reference

12 December 2020

10.1007/S12072-011-9266-Y

Identifiers

DOI

1 reference

12 September 2017

1 reference